The Illumiscreen advantage
The Illumiscreen prenatal test leverages the power of massively parallel sequencing (MPS) across the whole genome. The industry’s deepest sequencing approach combined with a highly optimised algorithm provides a clearer, more reliable answer than other methods.
Providing reliable, comprehensive answers about the health of a developing fetus
The Illumiscreen test from Illumina represents a major advance in prenatal testing, providing highly sensitive and specific answers about fetal chromosomal health—without the risks associated with invasive procedures, such as amniocentesis or chorionic villus sampling (CVS). Performed as early as 10 weeks gestation, the Illumiscreen test demonstrates superb sensitivity and specificity for the most prevalent trisomies. An easy, noninvasive blood test delivering the answers you seek in just days.
The Illumiscreen prenatal test is easy to order and needs only 1 tube of blood (just a 7mL sample). Our reports are available in 5-7 business days after sample receipt.
A well organised and easy-to-read report
Basic reports contain results for chromosomes 21, 18 and 13. Test reports include one of three possible results for chromosomes 21, 18, and 13: No Aneuploidy Detected, Aneuploidy Detected, or Aneuploidy Suspected (Borderline Value).
For singleton pregnancies, sex chromosome results are reported in cases where requested. If there are no sex chromosome aneuploidies, then the report will indicate XX or XY status. (It is for the provider and patient to decide if the fetal sex information is to be revealed to the patient.)
It is recommended that no irreversible clinical decisions be made based on these screening results alone. If a definitive diagnosis is desired, chorionic villus sampling or amniocentesis should be undertaken.
The Illumiscreen test has an option to screen for additional chromosomal disorders such as DiGeorge or Prader-Willi syndromes. Microdeletions are available by special request and will incur additional costs.
What does it cost?
Currently, this testing is not covered under the community contract for funded pathology testing services and does incur a cost of $615.
There will also be an additional fee to collect the sample which can vary depending on which service provider you use.
- A simple blood test
- Safe from procedural risks of invasive procedures (amniocentesis/CVS)
- Lowest test failure rate among noninvasive prenatal tests
- Fast results – sent to the referrer in 5-7 business days after sample receipt
Download Illumiscreen Requisition Form
Test Performance and Limitations
Download Clinicians Guide